Healthcare
Advisory
United States
M&A Advisory
M&A Advisory Firm
Industry:
Healthcare
Location:
United States
Year:
2005
Full Credential Description
Atherogenics. United States. Announced Date 05/01/2005. Closed Date 05/01/2005. Deal value: $200m. Private offering of convertible notes due 2012. Industry: Atherogenics was a pharmaceutical company focused on the development of drugs for the treatment of chronic inflammatory diseases.
Measurable Results
$200.0M